News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Elevates HKEX (00388.HK) TP to $430, Keeps Rating at Neutral
UBS published a research report expecting HKEX (00388.HK)'s 2Q25 NPAT/ revenue to increase 35%/ 30% to $4.3 billion/ $7 billion each, 11%/ 7% higher than market consensus, main...
Reset
Send
The window will close in 5 seconds
<Research>UBS Elevates HKEX (00388.HK) TP to $430, Keeps Rating at Neutral
Close
Recommend
13
Positive
20
Negative
5
 
SHORT SELL
 
STOCK INFO

UBS published a research report expecting HKEX (00388.HK)  +3.000 (+0.703%)    Short selling $206.98M; Ratio 11.577%   's 2Q25 NPAT/ revenue to increase 35%/ 30% to $4.3 billion/ $7 billion each, 11%/ 7% higher than market consensus, mainly due to better-than-expected net investment income (NII). The broker anticipated full-year NPAT/ revenue to rise by 16% YoY to $15 billion/ $30 billion.

UBS also raised its 2025/ 2026/ 2027 ADT forecasts by 14%/ 9%/ 8% to $218 billion/ $185 billion/ $208 billion, and EPS forecasts by 5%/ 2%/ 4% to $11.9/ $10.5/ $11.5, respectively. Therefore, the broker elevated its target price from $393 to $430, with rating kept at Neutral.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-18 16:25.)

Related NewsDaiwa: Investors Expect a 'Consolidation Period' for CN Stocks Next 6 Mths; Low Expectations for Real Estate Stimulus

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.